A post by Vivian Cheng at Science Progress chronicles a recent accusation of data-falsification in a study on a bone-growth treatment. Timothy Kuklo, a former Army orthopedic surgeon now at Washington University in St. Louis authored an article in the British Journal of Bone and Joint Surgery that said Medtronic's Infuse was better at treating severe leg injuries suffered by soldiers than traditional therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.